EUVIMEDOpdag EUVIMED
Crossref

HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer

Xue Yang iD, Xiaoqing Cui, Ge Wang, Mengying Zhou, Yonglin Wu, Yaying Du, Xingrui Li, Tao Xu

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23773 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2024. Written by Xue Yang and 7 co-authors. Institution: Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei…. Major MEDLINE topics: Pyroptosis, Triple Negative Breast Neoplasms, Tumor Microenvironment, Histone Deacetylase Inhibitors. Cited 18 times so far (Crossref); 49 references. Funded by: Key Research and Development Program of Hubei Province, Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Tongji Hospital, Knowledge Innovation Program of Wuhan-Shuguang Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Pyroptosis, an inflammatory form of cell death, promotes the release of immunogenic substances and stimulates immune cell recruitment, a process, which could turn cold tumors into hot ones. Thus, instigating pyroptosis in triple‐negative breast cancer (TNBC) serves as a viable method for restoring antitumor immunity. We analyzed the effects of Histone Deacetylase Inhibitors (HDACi) on TNBC cells using the Cell Counting Kit‐8 and colony formation assay. Apoptosis and lactate dehydrogenase (LDH) release assays were utilized to determine the form of cell death. The pyroptotic executor was validated by quantitative real‐time polymerase chain reaction and western blot. Transcriptome was analyzed to investigate pyroptosis‐inducing mechanisms. A subcutaneously transplanted tumor model was generated in BALB/c mice to evaluate infiltration of immune cells. HDACi significantly diminished cell proliferation, and pyroptotic “balloon”‐like cells became apparent. HDACi led to an intra and extracellular material exchange, signified by the release of LDH and the uptake of propidium iodide. Among the gasdermin family, TNBC cells expressed maximum quantities of GSDME, and expression of GSDMA, GSDMB, and GSDME were augmented post HDACi treatment. Pyroptosis was instigated via the activation of the caspase 3‐GSDME pathway with the potential mechanisms being cell cycle arrest and altered intracellular REDOX balance due to aberrant glutathione metabolism. In vivo experiments demonstrated that HDACi can activate pyroptosis, limit tumor growth, and escalate CD8+ lymphocyte and CD11b+ cell infiltration along with an increased presence of granzyme B in tumors. HDACi can instigate pyroptosis in TNBC, promoting infiltration of immune cells and consequently intensifying the efficacy of anticancer immunity.

Subjects

MeSH terms (MEDLINE)

PyroptosisTriple Negative Breast NeoplasmsTumor MicroenvironmentHistone Deacetylase InhibitorsMice, Inbred BALB CAnimalsFemaleMiceHumansCell Line, TumorCell ProliferationXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticApoptosis

Author keywords

HDACiTNBCantitumor immunitypyroptosis

Substances

Histone Deacetylase Inhibitors

Authors and institutions

  • Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China.
  • Laboratory of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China.
  • Laboratory of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China.
  • Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Department of Obstetrics and Gynecology, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China.

ORCID profiles: Xue Yang

Funding

  • Key Research and Development Program of Hubei Province
  • Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Tongji Hospital
  • Knowledge Innovation Program of Wuhan-Shuguang Project

Cite

APA

Yang, X., Cui, X., Wang, G., Zhou, M., Wu, Y., Du, Y., Li, X., & Xu, T. (2024). HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23773

Vancouver

Yang X, Cui X, Wang G, Zhou M, Wu Y, Du Y, et al. HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23773

BibTeX
@article{Yang2024,
  author = {Yang, Xue and Cui, Xiaoqing and Wang, Ge and Zhou, Mengying and Wu, Yonglin and Du, Yaying and Li, Xingrui and Xu, Tao},
  title = {HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23773}
}
Start for free →